Rajan Sharma

Stock Analyst at Goldman Sachs

(0.40)

# 3,941

Out of 4,754 analysts

4

Total ratings

33.33%

Success rate

-12.27%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$76.10	+27.46%	1	May 30, 2024
	GSK GSK plc	Initiates: Neutral	$47	$37.95	+23.85%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$28.88	+173.55%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $76.10

Upside: +27.46%

GSK plc

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $37.95

Upside: +23.85%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $28.88

Upside: +173.55%